Publications (135) LUIS IGNACIO FERNANDEZ SALAZAR publications

filter_list

2025

  1. Ileal Predominance in Crohn's Disease Is Associated With Increased Intestinal Surgery and Biological Therapy Use, With Lower Treatment Persistence

    The American journal of gastroenterology, Vol. 120, Núm. 1, pp. 194-203

  2. Management of Helicobacter pylori Infection in Spain Beyond the Data Collected in the European Registry on H. pylori Management (Hp-EuReg): Results of a Nationwide Survey

    Helicobacter, Vol. 30, Núm. 2

  3. Secondary aorto-duodenal fistula: a diagnostic challenge in a patient with fever and anemia

    Revista espanola de enfermedades digestivas, Vol. 117, Núm. 3, pp. 160-161

  4. Tofacitinib downregulates JAK1 and JAK3 on human intestinal monocytes and macrophages without affecting dendritic cells phenotype or function

    Journal of Translational Autoimmunity, Vol. 10

  5. Withdrawal of antitumour necrosis factor in inflammatory bowel disease patients in remission: a randomised placebo-controlled clinical trial of GETECCU

    Gut, Vol. 74, Núm. 3, pp. 387-396

2024

  1. Aplicación racional de las recomendaciones ESPGHAN 2022 de seguimiento del paciente celíaco pediátrico: documento de consenso de sociedades científicas (SEGHNP, AEPap, SEPEAP, SEEC, AEG, SEPD, SEMFYC, SEMG y SEMERGEN)

    Anales de Pediatría: Publicación Oficial de la Asociación Española de Pediatría ( AEP ), Vol. 101, Núm. 4, pp. 267-277

  2. Biological variability of human intraepithelial lymphocytes throughout the human gastrointestinal tract in health and coeliac disease

    European Journal of Clinical Investigation, Vol. 54, Núm. 12

  3. Complex immune network and regional consistency in the human gastric mucosa revealed by high-resolution spectral cytometry

    Scientific Reports, Vol. 14, Núm. 1

  4. Influence of familial forms of inflammatory bowel disease on the use of immunosuppressants, biological agents, and surgery in the era of biological therapies. Results from the ENEIDA project

    Postgraduate Medical Journal, Vol. 100, Núm. 1189, pp. 836-844

  5. Role of proton pump inhibitors dosage and duration in Helicobacter pylori eradication treatment: Results from the European Registry on H. pylori management

    United European Gastroenterology Journal, Vol. 12, Núm. 1, pp. 122-138

  6. Sex-Related Differences in the Phenotype and Course of Inflammatory Bowel Disease: SEXEII Study of ENEIDA

    Clinical Gastroenterology and Hepatology, Vol. 22, Núm. 11, pp. 2280-2290

  7. Trends in Targeted Therapy Usage in Inflammatory Bowel Disease: TRENDY Study of ENEIDA

    Pharmaceutics, Vol. 16, Núm. 5

2023

  1. Bismuth quadruple three-in-one single capsule three times a day increases effectiveness compared with the usual four times a day schedule: results from the European Registry on Helicobacter pylori Management (Hp-EuReg)

    Gut, Vol. 72, Núm. 11, pp. 2031-2037

  2. Early-onset colorectal cancer: an eleven-year analysis of clinicopathological characteristics at a tertiary healthcare center

    Arquivos de Gastroenterologia, Vol. 60, Núm. 3, pp. 315-321

  3. Empirical rescue treatment of Helicobacter pylori infection in third and subsequent lines: 8-year experience in 2144 patients from the European Registry on H. pylori management (Hp-EuReg)

    Gut, Vol. 72, Núm. 6, pp. 1054-1072

  4. Esophageal epidermoid metaplasia. An unusual find

    Revista espanola de enfermedades digestivas, Vol. 115, Núm. 4, pp. 194-195

  5. Helicobacter pylori Diagnostic Tests Used in Europe: Results of over 34,000 Patients from the European Registry on Helicobacter pylori Management

    Journal of Clinical Medicine, Vol. 12, Núm. 13

  6. Incidence, and natural history of inflammatory bowel disease in Castilla y León: Prospective and multicenter epidemiological study

    Gastroenterologia y Hepatologia, Vol. 46, Núm. 2, pp. 102-108

  7. Influence of enlarged waist circumference and hypertriglyceridemia in the severity of acute pancreatitis: A retrospective study

    Gastroenterologia y Hepatologia, Vol. 46, Núm. 10, pp. 795-802

  8. Plasma levels of intestinal fatty-acid binding protein (I-FABP), abdominal distension and hydrogen concentration after lactitol small intestinal bacterial overgrowth (SIBO) test

    Revista espanola de enfermedades digestivas, Vol. 115, Núm. 12, pp. 727-728